Core concept
Many cancers provoke persistent (chronic) inflammation at the tumor site.
Instead of protecting the host, the inflammatory response becomes a powerful ally of tumor progression.
Inflammation:
- supplies growth signals
- remodels tissue
- alters immune balance
- promotes invasion & metastasis
- drives systemic effects like cachexia
1️⃣ Why inflammation happens in cancers
- Tumors invading tissue cause damage → the body initiates an inflammatory response.
- As cancer persists & spreads, inflammation becomes chronic → pathological remodeling.
- Advanced cancers → systemic inflammation → whole-body effects:
- anemia of chronic disease
- fatigue
- cancer cachexia (muscle/fat wasting)
Key logic:
Never-ending “battlefield” drains the host and feeds tumor biology.
2️⃣ How inflammatory cells promote tumor growth
Main helpers = macrophages, neutrophils, mast cells, stromal fibroblasts.
Mechanisms:
- release of growth factors such as EGF → direct proliferative signaling
- secretion of proteases (MMPs, cathepsins):
- degrade ECM
- release ECM-bound growth factors
Result: tumor receives fuel + space to expand.
3️⃣ Inflammation removes natural growth restraints
Normal restraints:
- cell-cell and cell-matrix adhesion limit replication
- ECM acts as a physical brake
Inflammatory proteases:
- degrade adhesion molecules (e.g., cadherins, integrins)
- degrade ECM scaffolding
Effect: loss of contact inhibition → uncontrolled proliferation.
4️⃣ Anoikis resistance
- Anoikis = apoptosis triggered when epithelial cells detach from ECM.
- A key anti-cancer safeguard: prevents wandering cells from colonizing elsewhere.
Tumor-associated macrophages:
- express integrins/adhesion ligands
- provide survival signals → prevent anoikis
- enable detached cells to survive during invasion/metastasis
Mechanistic implication: survival advantage for migrating malignant cells.
5️⃣ Inflammatory promotion of angiogenesis
Pro-angiogenic mediators released by tumor-associated inflammatory cells:
- VEGF
- FGF
- PDGF
- TNF and IL-1 enhance VEGF expression
Outcomes:
- new vessels supply O₂/nutrients
- facilitate removal of metabolic waste
- provide routes for metastasis
6️⃣ Inflammation enhances invasion & metastasis
Key roles of inflammatory mediators:
- ECM breakdown
- proteases remodel matrix → create migration channels
- Motility stimulation
- TNF and EGF enhance cell movement
- Epithelial-to-Mesenchymal Transition (EMT)
- triggered by TGF-β
- epithelial → motile mesenchymal phenotype
- required for metastasis
Result: invasion beyond basement membrane + dissemination via vessels.
7️⃣ Immune suppression driven by inflammation
Chronic tumor inflammation shifts toward an M2-like wound-healing phenotype.
Mechanisms:
- TGF-β secretion suppresses cytotoxic responses
- recruitment of T regulatory cells (Tregs)
- suppression of CD8⁺ cytotoxic T cells
- macrophages produce angiogenic and fibrogenic factors → tumor stroma support
Conceptual model:
Tumor microenvironment resembles a “wound that won’t heal.”
8️⃣ Can targeting inflammation reduce cancer risk?
Yes. Anti-inflammatory therapy reduces tumor-promoting inflammation.
Evidence:
- Aspirin and COX-2 inhibitors lower colorectal cancer risk
- COX-2 promotes prostaglandin-mediated inflammation → angiogenesis + growth
Therapeutic rationale:
- block inflammatory drivers of tumor progression.
9️⃣ Why hallmarks matter clinically
- They guide how therapies are designed.
- Each hallmark = a pathway that can be therapeutically inhibited.
Inflammation impacts multiple hallmarks simultaneously:
- sustaining proliferative signaling
- activating invasion/metastasis
- resisting cell death
- inducing angiogenesis
- evading immune destruction
🔁 Ultra-Quick Recap Table
Effect | Mechanism | |
↑ Proliferation | growth factors (EGF) + protease liberation of ECM-bound factors | |
Remove Growth Suppressors | proteases degrade adhesion/ECM brakes | |
Resist Anoikis | macrophage integrins support survival of detached cells | |
Angiogenesis | VEGF & other angiogenic mediators | |
Invasion/Metastasis | proteases remodel ECM + EMT (TGF-β) + TNF/EGF promote motility | |
Immune Evasion | TGF-β, Tregs, M2 macrophages suppress CD8⁺ cytotoxicity | |
Therapeutic potential | COX-2 inhibitors, aspirin reduce inflammatory signaling |
One-screen story to lock memory
- Feed & Free
- Cut the Brakes
- Don’t Fall
- Build Roads
- Make Exits
- Mute the Cops
- Target the Helpers
- Use the Map
Growth signals + proteases free growth factors.
Proteases shred adhesion → uncontrolled expansion.
Integrin signals prevent anoikis so travelers survive.
VEGF makes new vessels to supply the growing tumor.
ECM remodeling + EMT + motility signals → escape routes & spread.
TGF-β + Tregs shut down anti-tumor immunity; M2 macrophages help rebuild stroma.
Anti-inflammatories block the inflammatory support team.
Hallmarks provide therapeutic targets.